EMD Serono Advances Patient Access to IVF Medicines in the US with New Pathways and Trump Administration Collaboration.
ByAinvest
Friday, Feb 6, 2026 8:04 am ET1min read
MRK--
EMD Serono, a healthcare business of Merck KGaA, has collaborated with the Trump Administration to expand access to its fertility medication portfolio in the US. Prescribed patients can now access a single coupon covering the company's complete fertility medication portfolio on TrumpRx.gov. The collaboration aims to make infertility treatments more accessible to the 10 million women in the US who struggle to have a baby.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet